Enzyme responsive release is an innovative mechanism used in cancer therapy to improve the targeted delivery of therapeutic agents. This approach leverages the unique enzymatic environment of cancerous tissues to trigger the release of drugs, ensuring they are released precisely where they are needed, thereby minimizing side effects on healthy tissues.
